Françoise Baylis | May 10, 2022
At the end of 2021, 57-year old David Bennett Sr. was bedridden and on life-support with irreversible heart failure. He was not eligible for a human heart transplant or an implanted mechanical heart pump because of his underlying health condition and, allegedly, “a history of disregarding medical advice.”
Françoise Baylis & Séverine Caluwaerts | November 25, 2016
Séverine Caluwaerts and Françoise Baylis lament the fact that in an epidemic as deadly as Ebola, pregnant women were denied access to potentially life-saving vaccination solely on the grounds of pregnancy.
Françoise Baylis | September 28, 2016
Some people criticize Bill S-201 – most notably insurers. They worry about clients taking a genetic test, getting results that suggest an increased risk of developing a specific “genetic illness” and then “bulking up” on insurance.
Françoise Baylis | September 26, 2016
Françoise Baylis discusses the response of the Canadian insurance industry to Bill S-201, An Act to prohibit and prevent genetic discrimination. […] If Bill S-201 becomes law, there is no doubt that this legislation will have an impact on the sale of life and health insurance.
Françoise Baylis | September 1, 2016
Françoise Baylis explains Canada’s regulatory framework for human-nonhuman chimera research and suggests that the proposed changes to the NIH guidelines to permit the funding of such research may have implications for Canadian research.
Françoise Baylis | May 5, 2016
Françoise Baylis calls for a better alignment of the science and ethics of human embryo research. […] A scientific breakthrough has prompted a call to revisit the 14-day limit on human embryo research. Is this new technology enough to warrant a change in law or policy? Do we have “new and compelling ethical or scientific justification” to change the 14-day rule?